A Photoactivated Self‐Assembled Nanoreactor for Inducing Cascade‐Amplified Oxidative Stress toward Type I Photodynamic Therapy in Hypoxic Tumors
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202401787 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Xuan Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, China Pharmaceutical University, Nanjing, 210009, China. Hauptthemen laut MEDLINE: Photochemotherapy, Oxidative Stress, Cerium, Reactive Oxygen Species. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Type I photodynamic therapy (PDT) generates reactive oxygen species (ROS) through oxygen‐independent photoreactions, making it a promising method for treating hypoxic tumors. However, the superoxide anion (O 2 ∙ – ) generated usually exhibits a low oxidation capacity, restricting the antitumor efficacy of PDT in clinical practice. Herein, a photoactivated self‐assembled nanoreactor ( 1 ‐NBS@CeO 2 ) is designed through integration of type I PDT and cerium oxide (CeO 2 ) nanozymes for inducing cascade‐amplified oxidative stress in hypoxic tumors. The nanoreactor is constructed though co‐assembly of an amphiphilic peptide ( 1 ‐NBS) and CeO 2 , giving well‐dispersed spherical nanoparticles with enhanced superoxide dismutase (SOD)‐like and peroxidase (POD)‐like activities. Following light irradiation, 1 ‐NBS@CeO 2 undergoes type I photoreactions to generated O 2 ∙ – , which is further catalyzed by the nanoreactors, ultimately forming hypertoxic hydroxyl radical (∙OH) through cascade‐amplified reactions. The PDT treatment using 1 ‐NBS@CeO 2 results in elevation of intracellular ROS and depletion of GSH content in A375 cells, thereby inducing mitochondrial dysfunction and triggering apoptosis and ferroptosis of tumor cells. Importantly, intravenous administration of 1 ‐NBS@CeO 2 alongside light irradiation showcases enhances antitumor efficacy and satisfactory biocompatibility in vivo. Together, the self‐assembled nanoreactor facilitates cascade‐amplified photoreactions for achieving efficacious type I PDT, which holds great promise in developing therapeutic modules towards hypoxic tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, China Pharmaceutical University, Nanjing, 210009, China.
- Key Laboratory of Biomedical Functional Materials, China Pharmaceutical University, Nanjing, 210009, China.
- Key Laboratory of Drug Quality Control and Pharmacovigilance, China Pharmaceutical University, Nanjing, 210009, China.
ORCID-Profile: Wenying Zhong
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Luo, X., Jiao, Q., Pei, S., Zhou, S., Zheng, Y., Shao, W., Xu, K., & Zhong, W. (2024). A Photoactivated Self‐Assembled Nanoreactor for Inducing Cascade‐Amplified Oxidative Stress toward Type I Photodynamic Therapy in Hypoxic Tumors. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401787
Vancouver
Luo X, Jiao Q, Pei S, Zhou S, Zheng Y, Shao W, et al. A Photoactivated Self‐Assembled Nanoreactor for Inducing Cascade‐Amplified Oxidative Stress toward Type I Photodynamic Therapy in Hypoxic Tumors. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401787
BibTeX
@article{Luo2024,
author = {Luo, Xuan and Jiao, Qishu and Pei, Shicheng and Zhou, Shuyao and Zheng, Yaxin and Shao, Weiyang and Xu, Keming and Zhong, Wenying},
title = {A Photoactivated Self‐Assembled Nanoreactor for Inducing Cascade‐Amplified Oxidative Stress toward Type I Photodynamic Therapy in Hypoxic Tumors},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202401787}
}
EUVIMED